Abstract
Different medicinal products can be used to treat various disorders. Finding promising compounds for both established and new illnesses is the goal of drug development. Finding new therapeutic uses for already-approved, withdrawn-from-use, abandoned, and experimental medications is the process of "drug repurposing." Recently, the medication rosiglitazone (ROSI) was used as an anticancer agent. The status and its application as an anticancer agent are described in the current review. In this review, we outlined the function of ROSI as an anticancer agent and covered a variety of ROSI-related topics, including its molecular mechanism of action, anti-angiogenesis properties, function in oxidative stress and inflammation, function in apoptosis and cell cycle, function in cell migration and invasion, and the use of ROSI in combination therapy with other drug agents.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
